# FDA Inspection 1003114 - Homeolab USA Inc. - January 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/homeolab-usa-inc/1fbeabbd-6f08-4524-b8e1-efe8f7c34d52
Source feed: FDA_Inspections

> FDA Inspection 1003114 for Homeolab USA Inc. on January 13, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003114
- Company Name: Homeolab USA Inc.
- Inspection Date: 2017-01-13
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 852340 - 2013-09-06](https://www.keypedia.com/records/fda_inspections/homeolab-usa-inc/00c22c49-84b9-42b6-af3c-653d87579724)

Company: https://www.keypedia.com/companies/homeolab-usa-inc/67d27091-bf11-449c-ae0b-0d2b8b2939ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c